Form 4: Hippo Director Susan Holliday Granted 2,502 RSUs

Sentiment:

Insider Transaction Report


Hippo Holdings Inc. director Susan Claire Holliday received a grant of 2,502 restricted stock units, aligning her interests with shareholders.

Summary

  • Susan Claire Holliday, a Director of Hippo Holdings Inc. (HIPO), was granted 2,502 Restricted Stock Units (RSUs).
  • The transaction date for this acquisition was October 1, 2025.
  • Each RSU entitles the reporting person to receive one share of Common Stock upon vesting.
  • The RSUs will vest in full upon the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant date, contingent on continued service to the Issuer.

Sentiment

Score: 6

Explanation: Slightly positive, as it represents a routine compensation event that aligns director interests with shareholders, without any negative implications.

Positives

  • The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, promoting long-term value creation.
  • Equity compensation is a common practice to attract and retain qualified board members.

Risks

  • The RSUs are subject to forfeiture if the reporting person's service to the Issuer and its subsidiaries ceases before the vesting date.

Future Outlook

The Restricted Stock Units are expected to vest in full upon the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting that occurs following the grant date, provided the director continues in service.

Industry Context

The grant of Restricted Stock Units is a standard practice in the technology and insurance industries for compensating directors and executives, aligning their long-term incentives with company performance and shareholder value.

Comparison to Industry Standards

  • This type of equity grant is consistent with compensation practices observed in comparable publicly traded companies within the Insurtech sector, such as Lemonade (LMND) or Root, Inc. (ROOT), where director compensation often includes a significant equity component to foster alignment with shareholder interests.
  • The vesting schedule, tied to continued service and an annual milestone, is a common mechanism to ensure retention and commitment from board members, similar to practices at companies like Oscar Health (OSCR) or Metromile (now part of Lemonade).

Related Party Transactions

  • The grant of Restricted Stock Units to a director constitutes a related party transaction, which is a standard form of compensation for board members.

Stakeholder Impact

  • Shareholders: The equity grant aligns the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term stock value.
  • Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

  • The Restricted Stock Units will vest upon the earlier of the first anniversary of the grant date (October 1, 2026) or immediately prior to the Annual Meeting following the grant date, subject to continued service.

Key Dates

DateDescription
10/01/2025Date of transaction for the acquisition of 2,502 Restricted Stock Units by Susan Claire Holliday.
10/03/2025Date the Form 4 was signed by Guy Zeltser, Attorney-in-Fact for Susan Claire Holliday.

Keywords

Hippo Holdings Inc., HIPO, SEC Form 4, Restricted Stock Units, RSU, Insider Transaction, Equity Compensation, Director Grant, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.